Christopher C. Gibson

Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation

Christopher C. Gibson, Weiquan Zhu, Chadwick T. Davis et al. · Circulation · 2014 · 179 citations · Full text

Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis.

Toshiya Doi, Liliane J. Striker, Christopher C. Gibson et al. · PubMed · 1990 · 168 citations

Interleukin receptor activates a MYD88–ARNO–ARF6 cascade to disrupt vascular stability

Weiquan Zhu, Nyall R. London, Christopher C. Gibson et al. · Nature · 2012 · 162 citations · Full text

Inflammation, Cytokine, Physiology +9

Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice

Aubrey C. Chan, Stavros G. Drakos, Oscar E. Ruiz et al. · Journal of Clinical Investigation · 2011 · 140 citations · Full text

Genetics, Vascular Malformation, Cell Death +24

Cationic PAMAM Dendrimers Disrupt Key Platelet Functions

Clinton F. Jones, Robert A. Campbell, Zechariah G. Franks et al. · Molecular Pharmaceutics · 2012 · 136 citations · Full text

Nanoparticles, Thrombosis, Nanomedicine +13